Cezary Szczylik

1952 -

country of citizenship: Poland

languages spoken, written or signed: Polish

Cezary Adam Szczylik (ur. 1 maja 1952) – polski profesor nauk medycznych specjalizujący się w onkologii, hematologii i chorobach wewnętrznych. Source: Wikipedia (pl)

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 249

Date

Title

Authors

2021-01-20

Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies

Cezary Szczylik, Claudine Kieda, Klaudia K Brodaczewska, Salem Chouaib
2020-03-25

Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo

Michal Fiedorowicz, Krzysztof Kilian, Anna M Czarnecka, Cezary Szczylik
2020-10-11

Aberrantly Expressed RECQL4 Helicase Supports Proliferation and Drug Resistance of Human Glioma Cells and Glioma Stem Cells

Sylwia K Król, Kamil Wojnicki, Bartosz Wojtas, Wojciech Kaspera, Bożena Kamińska-Kaczmarek, Cezary Szczylik, Wiesława Grajkowska, Bartłomiej Gielniewski, Tomasz Czernicki, Ryszard Czepko
2020-10-01

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy

Dawid Sigorski, Michal Wilk, Cezary Szczylik, Lubomir Bodnar, Rafal Stec, Piotr Rutkowski
2019-09-18

Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance

Anna M Czarnecka, Cezary Szczylik, Ewa Bartnik, Zofia F Bielecka, Klaudia K Brodaczewska
2019-10-10

Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities

Anna Brodziak, Paweł Sobczuk, Michal Fiedorowicz, Anna M Czarnecka, Cezary Szczylik, Ewa Bartnik
2019-01-02

External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model

Pawel Chrom, Cezary Szczylik, Lubomir Bodnar
2019-06-06

Cancer stem cells in renal carcinoma

Michal Fiedorowicz, Anna M Czarnecka, Cezary Szczylik, Ewa Bartnik
2019-02-16

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Cezary Szczylik
2019-05-23

Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma

Anna M Czarnecka, Anna Brodziak, Paweł Sobczuk, Cezary Szczylik, Ewa Bartnik
2019-03-30

Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators

Sławomir Lewicki, Anna M Czarnecka, Cezary Szczylik
2018-12-31

Development of extracellular matrix supported 3D culture of renal cancer cells and renal cancer stem cells

Anna M Czarnecka, Cezary Szczylik, Anna Kornakiewicz, Zofia F Bielecka, Klaudia K Brodaczewska
2018-01-01

Prognostic Significance of Pancreatic Metastases from Renal Cell Carcinoma in Patients Treated with Tyrosine Kinase Inhibitors

Rafal Stec, Cezary Szczylik, Lubomir Bodnar, Pawel Chrom
2018-02-17

Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research model.

Anna M Czarnecka, Krzysztof M Krawczyk, Cezary Szczylik
2018-02-02

Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis

Rafal Stec, Stanisław Niemczyk, Cezary Szczylik, Arkadiusz Lubas, Aleksandra Semeniuk-Wojtaś, Tomasz Syryło
2018-06-01

Effect of Everolimus on Heterogenous Renal Cancer Cells Populations Including Renal Cancer Stem Cells

Anna Kornakiewicz, Anna M Czarnecka, Anna Kotrys, Cezary Szczylik
2018-03-05

Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance.

Gabriel Wcislo, Anna M Czarnecka, Sławomir Lewicki, Cezary Szczylik, Claudine Kieda
2018-05-08

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma.

Anna M Czarnecka, Rafal Stec, Cezary Szczylik, Lubomir Bodnar, Pawel Chrom
2018-03-05

Immune consequences of anti-angiogenic therapyin renal cell carcinoma.

Cezary Szczylik, Claudine Kieda, Klaudia K Brodaczewska
2018-05-23

Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma

Katarzyna Zielniok, Małgorzata Gajewska, Anna M Czarnecka, Cezary Szczylik, Claudine Kieda, Mohammed Imran Khan, Klaudia K Brodaczewska
2018-02-02

Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines

Lubomir Bodnar, Rafal Stec, Agnieszka Synowiec, Gabriel Wcislo, Cezary Szczylik, Szczepan Cierniak, Pawel Chrom
2018-10-24

Second-line cabozantinib versus nivolumab in advanced renal cell carcinoma: Systematic review and indirect treatment comparison

Cezary Szczylik
2017-01-05

Functional significance of CD105-positive cells in papillary renal cell carcinoma

Irena Koch, Sławomir Lewicki, Robert Zdanowski, Anna M Czarnecka, Cezary Szczylik, Klaudia K Brodaczewska
2017-03-20

Colony, hanging drop, and methylcellulose three dimensional hypoxic growth optimization of renal cell carcinoma cell lines

Anna M Czarnecka, Cezary Szczylik, Klaudia K Brodaczewska
2017-08-25

Renin angiotensin system deregulation as renal cancer risk factor

Paweł Sobczuk, Anna M Czarnecka, Cezary Szczylik
2017-12-16

Hypoxic 3D in vitro culture models reveal distinct resistance processes to TKIs in renal cancer cells

Anna M Czarnecka, Zofia F Bielecka, Agata Malinowska, Cezary Szczylik, Elżbieta Grzesiuk, Klaudia K Brodaczewska, Claudine Kieda
2017-12-29

Effects of cell-cell crosstalk on gene expression patterns in a cell model of renal cell carcinoma lung metastasis.

Anna M Czarnecka, Mohammed Imran Khan, Ewa Bartnik, Cezary Szczylik, Wojciech Fendler
2017-03-03

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model.

Rafal Stec, Cezary Szczylik, Lubomir Bodnar, Pawel Chrom
2016-12-20

Axitinib in sequential therapy in metastatic renal cell carcinoma

Rafal Stec, Michał Mączewski, Cezary Szczylik
2016-01-01

Problems of diagnostic assessment in advanced pancreatic neuroendocrine neoplasm and treatment implications: a case report and literature review

Grzegorz Kamiński, Cezary Szczylik, Renata Duchnowska
2016-06-08

Gene set enrichment analysis and ingenuity pathway analysis of metastatic clear cell renal cell carcinoma cell line

Anna M Czarnecka, Mohammed Imran Khan, Konrad Debski, Michał Dąbrowski, Cezary Szczylik
2016-03-28

Hormone signaling pathways as treatment targets in renal cell cancer (Review).

Anna M Czarnecka, Cezary Szczylik

Human - wd:Q9188497

Welcome to Inventaire

the library of your friends and communities

learn more